$BMRN #Stocks #StockMarket #BiomarinPharmaceutical reported Q1 EPS on https://t.co/savSNTKlN1: Due to strong revenue growth company turned into profitability, Sales grew by 25.284 % to $502.069 MM, EPS per share were at $0.44, compared to $-0.32 in the… https://t.co/eTBrtViTue